Chemotherapy Press Releases

IGH Naturals has initiated a clinical trial to evaluate Humolyte®, an oral solution aimed at reducing chemotherapy-related side effects and improving supportive care in oncology.

Selected patients preparing for chemotherapy will receive HuMOLYTE at no cost and provide feedback to support product development.

IGH Naturals Receives IRB Approval to Begin Clinical Trial on HuMOLYTE™ Impact on Hydration and Mucositis in Patients with Cancer Receiving Chemotherapy